Author

Y. Ziegler

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. N. Mogol· 1 shared A. S. Casiano· 1 shared A. S. Raghavendra· 1 shared B. H. Park· 1 shared B. Katzenellenbogen· 1 shared B. Pascal· 1 shared B. S. Katzenellenbogen· 1 shared C. C. Nettles· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. N. Mogol

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Targeting metabolic adaptations in the breast cancer liver metastatic niche using dietary approaches to improve endocrine therapy efficacy

Q. Zuo, A. N. Mogol, Y.-J. Liu, A. S. Casiano, C. Chien, J. Drnevich, O. B. Imir, E. Kulkoyluoglu-Cotul, N. H. Park, D. J. Shapiro, B. H. Park, Y. Ziegler, B. S. Katzenellenbogen, E. Aranda, J. D. O'Neill, , Z. Madak-Erdogan

This study identifies a mechanism of endocrine resistance in liver metastases of ER+ breast cancer and shows that a fasting-mimicking diet enhances the efficacy of fulvestrant treatment.

bioRxiv · Sep 7, 2021Cancer Biology

Dual mechanism estrogen receptor inhibitors

J. Min, J. C. Nwachukwu, S. Srinivasan, E. Rangarajan, C. C. Nettles, V. Sanabria Guillen, Y. Ziegler, S. Yan, K. Carlson, Y. Hou, S. H. Kim, S. Novick, B. Pascal, R. Houtman, P. Griffin, , K. W. Nettles

This paper develops dual-mechanism ER inhibitors that use two distinct targeting moieties to suppress ER activity in breast cancer cells and resistance models.

bioRxiv · Jul 6, 2020Cancer Biology